Healthcare M&A Due Diligence

Positioning leadership decisions, mitigating acquisition risks and protecting investments.

Healthcare mergers and acquisitions are a route to advancement in health and care. These deals can enable providers to expand into other regions, while potentially granting smaller services access to better infrastructure and governance integration.

However, Healthcare M&A decisions carry significant operational and compliance risks. So, investment decisions require vast considerations on commercial and compliance fronts, which must be supported by authoritative insights.

At Edmonds Governance & Strategy, we deliver M&A healthcare due diligence assessments through the lens of a former senior CQC regulator.

Using regulatory expertise, we help senior leaders to make confident investment decisions by providing an objective assessment of a provider’s regulatory position, compliance culture and operational effectiveness.

Our work supports organisations in identifying hidden risks to protect investments. Additionally, our process provides a clear baseline for post-acquisition stabilisation and improvement to ease processes and ensure the continuity of high-quality care.

Our Healthcare M&A Due Diligence Services Include:

Due Diligence Audits
Operational Efficiency Assessments
CQC Compliance Evaluations
Post-acquisition Stabilisation and Improvement Plans
Root-cause Analysis
Risk Assessments
Governance and Compliance Reviews

Why M&A Due Diligence Matters

For healthcare M&A decisions, it is vital to gain an expert’s input for every stage of the process. This supports long-term value in the deal and that the delivery of high-quality care continues. With Edmonds Governance & Strategy, direct frontline care and regulatory experiences from the UK healthcare sector shape our M&A due diligence processes.

We understand what regulators look for and where risks are most often hidden. Our approach provides leaders with a clear, independent oversight of both frontline care delivery and the governance structures that underpin it.

Utilizing specialized regulatory expertise, our frameworks extend beyond surface-level assessments. We evaluate the realities of compliance, leadership oversight, and organisational culture, providing boards and investors with the clarity and assurance needed to make informed decisions.

Additionally, our assessments don’t just stop at the point of a decision. Should the acquirement go through, our assessments will underpin improvement plans and stablisation from a former-CQC perspective.

Outcomes You Can Expect:

Reduced Risk In M&A Decisions

Objective Oversight Of Provider's Culture and Systems

Post-acquisition Stablisation and Improvement Overviews

Increased Confidence In Investment Decisions

Advance In Healthcare M&A With CQC Expertise

Every M&A decision presents its own risks and possibilities, but combining invaluable expertise in healthcare from regulatory, frontline and boardroom experience, our support informs leaders in their investment decisions.

Contact us for a free call today, to see where our healthcare M&A due diligence services can support your advancements in care.